Epidemiology and risk factors: intrahepatic cholangiocarcinoma.

Intrahepatic cholangiocarcinoma (ICC) is a rare entity with a distinct clinical course and epidemiology from hilar and extrahepatic cholangiocarcinoma. ICC makes up 8-10% of cholangiocarcinomas and 10-20% of all primary liver tumors. There remains a considerable amount of geographic variation in the incidence of ICC worldwide; however, the overall incidence of this malignancy appears to be rising. Several risk factors have been identified, such as infectious causes (liver flukes, viral hepatitis), biliary tract disease [primary sclerosing cholangitis (PSC), hepaticolithiasis, biliary cystic diseases], metabolic syndrome, lifestyle choices (alcohol abuse, tobacco use), and cirrhosis. Despite this, a substantial number of ICC patients do not have any identifiable risk factors, underlining the need for further work into the pathogenesis of this malignancy.

[1]  M. H. Jang,et al.  LIVER PATHOLOGY , 1955, Pediatric Gastrointestinal and Liver Disease.

[2]  D. Parkin,et al.  Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  K. Chayama,et al.  Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus–related cirrhosis , 2000, Cancer.

[4]  V. Castranova,et al.  Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma. , 2009, European journal of gastroenterology & hepatology.

[5]  Shogo Tanaka,et al.  Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan , 2014, Journal of hepato-biliary-pancreatic sciences.

[6]  M. Matsuda,et al.  Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin , 2007, Hepatology.

[7]  W. Palmer,et al.  Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. , 2012, Journal of hepatology.

[8]  F. Callea,et al.  Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy , 2001, Cancer Causes & Control.

[9]  S. Fan,et al.  Intrahepatic Cholangiocarcinoma , 1997, World Journal of Surgery.

[10]  M. Kinoshita,et al.  The association between non‐alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case‐control study , 2016, Journal of surgical oncology.

[11]  Y. Nakanuma,et al.  Precancerous lesions of intrahepatic cholangiocarcinoma. , 2000, Journal of hepato-biliary-pancreatic surgery.

[12]  K. Straif,et al.  Carcinogenicity of perfluorooctanoic acid, tetrafluoroethylene, dichloromethane, 1,2-dichloropropane, and 1,3-propane sultone. , 2014, The Lancet. Oncology.

[13]  Jung-Hwan Yoon,et al.  Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. , 2010, Cancer research.

[14]  Hai-rim Shin,et al.  Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. , 1996, International journal of epidemiology.

[15]  B. Graubard,et al.  Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.

[16]  K. McGlynn,et al.  Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. , 2005, Gastroenterology.

[17]  T. Patel,et al.  Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[18]  David Cosgrove,et al.  Intrahepatic cholangiocarcinoma: management options and emerging therapies. , 2013, Journal of the American College of Surgeons.

[19]  N. Kurumatani,et al.  Cholangiocarcinoma among offset colour proof-printing workers exposed to 1,2-dichloropropane and/or dichloromethane , 2013, Occupational and Environmental Medicine.

[20]  Steven C Cunningham,et al.  Cholangiocarcinoma: Thirty-one-Year Experience With 564 Patients at a Single Institution , 2007, Annals of surgery.

[21]  Celia P. Corona-Villalobos,et al.  Multidisciplinary approaches to intrahepatic cholangiocarcinoma , 2013, Cancer.

[22]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[23]  R. Chapman.  Risk factors for biliary tract carcinogenesis. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[24]  E. Kouroumalis,et al.  Increasing incidence of cholangiocarcinoma in Crete 1992-2000. , 2002, Anticancer research.

[25]  M. Choti,et al.  Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. , 2006, Human pathology.